160 related articles for article (PubMed ID: 19093772)
1. Future of idiotypic vaccination for B-cell lymphoma.
de Cerio AL; Inogés S
Expert Rev Vaccines; 2009 Jan; 8(1):43-50. PubMed ID: 19093772
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
[TBL] [Abstract][Full Text] [Related]
3. Idiotype vaccines for lymphoma therapy.
Inogés S; de Cerio AL; Villanueva H; Soria E; Pastor F; Bendandi M
Expert Rev Vaccines; 2011 Jun; 10(6):801-9. PubMed ID: 21692701
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of idiotype vaccination in relapsed B-cell malignancies.
Inogés S; Rodríguez-Calvillo M; López-Díaz de Cerio A; Zabalegui N; Pérez-Calvo J; Panizo C; Hernandez M; Cuesta B; Rocha E; Bendandi M
Haematologica; 2003 Dec; 88(12):1438-40. PubMed ID: 14688006
[No Abstract] [Full Text] [Related]
5. The role of idiotype vaccines in the treatment of human B-cell malignancies.
Bendandi M
Expert Rev Vaccines; 2004 Apr; 3(2):163-70. PubMed ID: 15056042
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial.
Thomas SK; Kwak LW
Semin Oncol; 2012 Jun; 39(3):253-62. PubMed ID: 22595048
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
[TBL] [Abstract][Full Text] [Related]
9. BiovaxID®: a customized idiotype vaccine for the treatment of B-cell lymphoma.
Villanueva H; de Cerio AL; Inoges S; Pastor F; Soldevilla MM; Bendandi M
Expert Rev Vaccines; 2011 Dec; 10(12):1661-9. PubMed ID: 22085168
[TBL] [Abstract][Full Text] [Related]
10. [Past, present and future of anti-idiotype vaccination].
Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
[TBL] [Abstract][Full Text] [Related]
11. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
Bendandi M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):65-72. PubMed ID: 12113135
[TBL] [Abstract][Full Text] [Related]
12. BiovaxID, a personalized therapeutic vaccine against B-cell lymphomas.
Reinis M
Curr Opin Mol Ther; 2008 Oct; 10(5):526-34. PubMed ID: 18830928
[TBL] [Abstract][Full Text] [Related]
13. Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders.
Milosević DB
J Exp Clin Cancer Res; 2004 Mar; 23(1):9-13. PubMed ID: 15149145
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma vaccine trial: one step forward in long trek.
Schmidt C
J Natl Cancer Inst; 2009 Sep; 101(18):1228-9, 1232. PubMed ID: 19738162
[No Abstract] [Full Text] [Related]
15. [Vaccination against cancer soon a therapeutic possibility. B-cell tumors, colonic cancer and melanoma may be suitable for this treatment].
Mellstedt H; Fagerberg J; Osterborg A
Lakartidningen; 1998 Mar; 95(13):1405-10. PubMed ID: 9560967
[TBL] [Abstract][Full Text] [Related]
16. Vaccine therapy for B-cell lymphomas: next-generation strategies.
Neelapu SS; Kwak LW
Hematology Am Soc Hematol Educ Program; 2007; ():243-9. PubMed ID: 18024636
[TBL] [Abstract][Full Text] [Related]
17. Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.
Muraro E; Martorelli D; Dolcetti R
Hum Vaccin Immunother; 2013 May; 9(5):1078-83. PubMed ID: 23406835
[TBL] [Abstract][Full Text] [Related]
18. Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination.
Cesco-Gaspere M; Zentilin L; Giacca M; Burrone OR
Scand J Immunol; 2008 Jul; 68(1):58-66. PubMed ID: 18482206
[TBL] [Abstract][Full Text] [Related]
19. Environmental enrichment augments the efficacy of idiotype vaccination for B-cell lymphoma.
Benaroya-Milshtein N; Apter A; Yaniv I; Kukulansky T; Raz N; Haberman Y; Halpert H; Pick CG; Hollander N
J Immunother; 2007; 30(5):517-22. PubMed ID: 17589292
[TBL] [Abstract][Full Text] [Related]
20. Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development.
Rodríguez-Calvillo M; Inogés S; López-Díaz de Cerio A; Zabalegui N; Villanueva H; Bendandi M
Crit Rev Oncol Hematol; 2004 Oct; 52(1):1-7. PubMed ID: 15363462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
